Catheter Precision Files 8-K on Financials

TL;DR

Catheter Precision dropped an 8-K on April 1st covering financials - check it out.

AI Summary

Catheter Precision, Inc. filed an 8-K on April 2, 2024, reporting on its results of operations and financial condition as of April 1, 2024. The filing also includes financial statements and exhibits. The company was formerly known as Ra Medical Systems, Inc. before changing its name on September 8, 2017.

Why It Matters

This 8-K filing provides an update on Catheter Precision's financial status and operational results, which is crucial information for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or significant risks.

Key Players & Entities

• Catheter Precision, Inc. (company) — Registrant
• Ra Medical Systems, Inc. (company) — Former company name
• April 1, 2024 (date) — Date of earliest event reported
• April 2, 2024 (date) — Date of report
• September 8, 2017 (date) — Date of name change

FAQ

Key Financial Figures

• $0.0001 — ich registered Common Stock, par value $0.0001 per share VTAK NYSE American Indic

Filing Documents

• rmed_8k.htm (8-K) — 26KB
• rmed_ex991.htm (EX-99.1) — 19KB
• rmed_ex991img1.jpg (GRAPHIC) — 4KB
• 0001654954-24-004178.txt ( ) — 178KB
• vtak-20240401.xsd (EX-101.SCH) — 6KB
• vtak-20240401_lab.xml (EX-101.LAB) — 14KB
• vtak-20240401_cal.xml (EX-101.CAL) — 1KB
• vtak-20240401_pre.xml (EX-101.PRE) — 9KB
• vtak-20240401_def.xml (EX-101.DEF) — 2KB
• rmed_8k_htm.xml (XML) — 4KB

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On April 1, 2024, Catheter Precision, Inc. (formerly known as Ra Medical Systems, Inc.) (the "Company") issued a press release announcing its financial results for the quarter and year ended December 31, 2023. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 2.02, Exhibit 99.1 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in this current report shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered "filed" or incorporated by reference therein.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit Description 99.1 Press Release Issued on April 1, 2024 104 Cover Page Interactive Data File (formatted as inline XBRL) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CATHETER PRECISION, INC. Date: April 2, 2024 By: /s/ David A. Jenkins David A. Jenkins Chief Executive Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR